Treatment of inflammatory muscle disease in adults

Joint, Bone, Spine : Revue Du Rhumatisme
Anne TournadreMartin Soubrier

Abstract

Inflammatory muscle disease is a term used to designate a heterogeneous group of autoimmune diseases of unknown etiology whose main target is the skeletal muscle. Clinical, histological, and immunopathological criteria are classically used to distinguish polymyositis, dermatomyositis, and inclusion body myositis. Major obstacles to controlled therapeutic trials in patients with inflammatory muscle diseases include the heterogeneity of these diseases, their low prevalence, and the absence of validated evaluation criteria. To date, no such trials are available and the treatment is therefore largely empirical. Glucocorticoids are usually given first. Methotrexate is then added in the event of resistance to, or dependency on, glucocorticoid therapy. Methotrexate may be used from the outset in patients with severe disease in an attempt to decrease the glucocorticoid requirements. However, no controlled trials have been conducted to determine whether first-line methotrexate therapy improves outcomes. Intravenous immunoglobulin infusion is a costly treatment option that is reserved for the following situations: refractory dermatomyositis, based on a trial showing superiority over a placebo; myositis with impaired swallowing; and patie...Continue Reading

References

Jun 19, 1975·The New England Journal of Medicine·W RawlingsR Humphrey
Feb 20, 1975·The New England Journal of Medicine·A Bohan, J B Peter
May 21, 1992·The New England Journal of Medicine·F W MillerP H Plotz
Mar 1, 1987·Arthritis and Rheumatism·R M LaxerR E Petty
Jul 1, 1985·The Journal of Clinical Endocrinology and Metabolism·F F HorberF J Frey
Mar 1, 1980·Annals of Internal Medicine·T W BunchA G Engel
Aug 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·S MatsubaraH Kida
Dec 30, 1993·The New England Journal of Medicine·M C DalakasS McCrosky
Jun 20, 2003·Joint, Bone, Spine : Revue Du Rhumatisme·Agathe Imbert-MasseauPascal Chérin
May 20, 2004·JAMA : the Journal of the American Medical Association·Marinos C Dalakas
Feb 5, 2005·Arthritis and Rheumatism·Todd D Levine
Dec 17, 2005·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Nicole ChiappettaBarry Gruber
Jan 18, 2006·Archives of Dermatology·Johnathon C EdgeJeffrey P Callen
Jan 25, 2006·Neurology·R J BarohnJ R Mendell
Apr 12, 2006·Annals of the Rheumatic Diseases·I M BronnerJ E Hoogendijk
Apr 26, 2006·Neurology·J RowinM N Meriggioli
Jun 14, 2006·Annals of the Rheumatic Diseases·L BrulhartC Gabay
Sep 9, 2006·The Journal of Rheumatology·Florenzo IannoneGiovanni Lapadula
Sep 28, 2006·Rheumatology·C N PisoniD P D'Cruz
Nov 14, 2006·Journal of the American Academy of Dermatology·Hope V DinhH Miles Prince
Nov 18, 2006·Joint, Bone, Spine : Revue Du Rhumatisme·Christelle SordetJean Sibilia
May 29, 2007·Arthritis and Rheumatism·Helene AlexandersonIngrid E Lundberg
Jun 20, 2007·Archives of Dermatology·Lorinda ChungDavid F Fiorentino
Nov 9, 2007·Joint, Bone, Spine : Revue Du Rhumatisme·Zahi ToumaAbdel Fattah Masri
Jan 16, 2008·Journal of the American Academy of Dermatology·J Scott Boswell, Melissa I Costner
Jan 31, 2008·European Neurology·G J D HengstmanF H J van den Hoogen
Apr 15, 2008·Annals of the Rheumatic Diseases·V S SangleD P D'Cruz
Apr 22, 2008·Journal of the American Academy of Dermatology·Luciano J Iorizzo, Joseph L Jorizzo
May 6, 2008·Joint, Bone, Spine : Revue Du Rhumatisme·Anne TournadreMartin Soubrier

❮ Previous
Next ❯

Citations

Dec 29, 2015·Expert Review of Clinical Pharmacology·Serena FasanoDavid A Isenberg
Sep 20, 2015·International Journal of Rheumatic Diseases·Syed A Haq, Anne Tournadre
Oct 16, 2012·Revue de pneumologie clinique·F FrikhaZ Bahloul
Dec 20, 2011·European Journal of Cell Biology·Clara CrescioliLuigi Di Luigi
Dec 30, 2011·La Revue de médecine interne·C DievalM Longy-Boursier
Aug 3, 2011·Joint, Bone, Spine : Revue Du Rhumatisme·Mariano Andres, Philip Courtney
Jun 15, 2011·Autoimmunity Reviews·Mariana Brandão, António Marinho
Mar 24, 2016·Revista brasileira de reumatologia·Orhan ZenginAhmet Mesut Onat
Jun 21, 2013·Journal of the Peripheral Nervous System : JPNS·Marzieh NiknamiJohn D Pollard
Jan 27, 2015·Annales de dermatologie et de vénéréologie·O NahasG Maalouly
Mar 19, 2013·The Journal of Rheumatology·Ilias N Lazarou, Pierre-André Guerne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Best Practice & Research. Clinical Rheumatology
Herman F MannI Lundberg
Joint, Bone, Spine : Revue Du Rhumatisme
Agathe Imbert-MasseauPascal Chérin
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Heinz Wiendl
Expert Opinion on Pharmacotherapy
Gerald J D HengstmanBaziel G M van Engelen
© 2021 Meta ULC. All rights reserved